Government
UK Startup OrganOx Secures $32.6M for Liver Transplantation Device
What You Should Know: – OrganOx, a United Kingdom-based medical technology company committed to making every donated organ count with metra®, a fully…
What You Should Know:
– OrganOx, a United Kingdom-based medical technology company committed to making every donated organ count with metra®, a fully automated normothermic machine perfusion (NMP) device for liver transplantation raises £25M ($32.6M USD) in a growth round led by Lauxera Capital Partners (“Lauxera”) with support from existing investors.
– The proceeds from the funding will enable OrganOx to significantly expand its commercial footprint across strategically key areas of the business. This includes expanding the customer-facing team in the United States due to high interest and adoption of the OrganOx technology.
Increasing the Number of Donors Available for Transplant
Based in Oxford, UK, OrganOx is a world leader in normothermic machine perfusion dedicated to saving lives by making every donated organ count. The multi-award-winning OrganOx metra uses proprietary NMP technology to preserve donor livers in a functioning state for up to 24 hours prior to transplant. metra is a fully automated NMP device that enables continuous monitoring and evaluation of the liver, empowering surgeons to make evidence-based decisions on whether to transplant a donor organ, enabling viability testing and transplant of previously declined organs. metra is commercially available in Europe (CE Mark) and the United States (FDA Approved: P200035).
Expansion Plans
In addition, investment will be made in new infrastructure in both the UK and the US over the coming months to facilitate and accelerate programs within the R&D pipeline, some of which will address large and underserved markets adjacent to liver transplantation.
Here Are the Champions! Our Top Performing Stories in 2023
It has been quite a year – not just for the psychedelic industry, but also for humanity as a whole. Volatile might not be the most elegant word for it,…
AI can already diagnose depression better than a doctor and tell you which treatment is best
Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…
Scientists use organoid model to identify potential new pancreatic cancer treatment
A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer…
